APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brain AI-assisted Diagnosis Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Brain AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032

6 March 2026192 pages

Choose your research edition.

Industry ResearchBrain AI-assisted Diagnosis Software Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Brain AI-assisted Diagnosis Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Brain AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brain AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Brain AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Brain AI-assisted Diagnosis Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Brain AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Brain AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Brain AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Brain AI-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Brain AI-assisted Diagnosis Software include Deepwise, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX and BioMind, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Brain AI-assisted Diagnosis Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Brain AI-assisted Diagnosis Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Brain AI-assisted Diagnosis Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Brain AI-assisted Diagnosis Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Brain AI-assisted Diagnosis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Brain AI-assisted Diagnosis Software revenue, projected growth trends, production technology, application and end-user industry.

Brain AI-assisted Diagnosis Software Segment by Company

Deepwise

NeuMiva

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

BioMind

NANO-X

Aikenist

VUNO

Brain AI-assisted Diagnosis Software Segment by Type

Cloud-based

On-Primes

Brain AI-assisted Diagnosis Software Segment by Application

Hospital

Clinic

Imaging Center

Brain AI-assisted Diagnosis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brain AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain AI-assisted Diagnosis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Brain AI-assisted Diagnosis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Brain AI-assisted Diagnosis Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brain AI-assisted Diagnosis Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Brain AI-assisted Diagnosis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-Primes Major Player Table 4. Global Brain AI-assisted Diagnosis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Imaging Center Major Player Table 8. Brain AI-assisted Diagnosis Software Industry Trends Table 9. Brain AI-assisted Diagnosis Software Industry Drivers Table 10. Brain AI-assisted Diagnosis Software Industry Opportunities and Challenges Table 11. Brain AI-assisted Diagnosis Software Industry Restraints Table 12. Global Brain AI-assisted Diagnosis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Brain AI-assisted Diagnosis Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Brain AI-assisted Diagnosis Software Market Share by Region (2021-2026) Table 15. Global Brain AI-assisted Diagnosis Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Brain AI-assisted Diagnosis Software Market Share by Region (2027-2032) Table 17. Global Brain AI-assisted Diagnosis Software Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Brain AI-assisted Diagnosis Software Revenue Market Share by Players (2021-2026) Table 19. Global Brain AI-assisted Diagnosis Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Brain AI-assisted Diagnosis Software Key Players Headquarters & Area Served Table 21. Global Brain AI-assisted Diagnosis Software Players, Product Type & Application Table 22. Global Brain AI-assisted Diagnosis Software Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Brain AI-assisted Diagnosis Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Brain AI-assisted Diagnosis Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Brain AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2026) Table 29. Global Brain AI-assisted Diagnosis Software Revenue Market Share by Type (2027-2032) Table 30. Global Brain AI-assisted Diagnosis Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Brain AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2026) Table 34. Global Brain AI-assisted Diagnosis Software Revenue Market Share by Application (2027-2032) Table 35. Deepwise Company Information Table 36. Deepwise Business Overview Table 37. Deepwise Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Deepwise Brain AI-assisted Diagnosis Software Product Portfolio Table 39. Deepwise Recent Development Table 40. NeuMiva Company Information Table 41. NeuMiva Business Overview Table 42. NeuMiva Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. NeuMiva Brain AI-assisted Diagnosis Software Product Portfolio Table 44. NeuMiva Recent Development Table 45. G K Healthcare Company Information Table 46. G K Healthcare Business Overview Table 47. G K Healthcare Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. G K Healthcare Brain AI-assisted Diagnosis Software Product Portfolio Table 49. G K Healthcare Recent Development Table 50. Sense Time Company Information Table 51. Sense Time Business Overview Table 52. Sense Time Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sense Time Brain AI-assisted Diagnosis Software Product Portfolio Table 54. Sense Time Recent Development Table 55. United Imaging Company Information Table 56. United Imaging Business Overview Table 57. United Imaging Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. United Imaging Brain AI-assisted Diagnosis Software Product Portfolio Table 59. United Imaging Recent Development Table 60. Infervision Company Information Table 61. Infervision Business Overview Table 62. Infervision Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Infervision Brain AI-assisted Diagnosis Software Product Portfolio Table 64. Infervision Recent Development Table 65. Shukun Company Information Table 66. Shukun Business Overview Table 67. Shukun Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Shukun Brain AI-assisted Diagnosis Software Product Portfolio Table 69. Shukun Recent Development Table 70. FOSUN AITROX Company Information Table 71. FOSUN AITROX Business Overview Table 72. FOSUN AITROX Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. FOSUN AITROX Brain AI-assisted Diagnosis Software Product Portfolio Table 74. FOSUN AITROX Recent Development Table 75. BioMind Company Information Table 76. BioMind Business Overview Table 77. BioMind Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BioMind Brain AI-assisted Diagnosis Software Product Portfolio Table 79. BioMind Recent Development Table 80. NANO-X Company Information Table 81. NANO-X Business Overview Table 82. NANO-X Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. NANO-X Brain AI-assisted Diagnosis Software Product Portfolio Table 84. NANO-X Recent Development Table 85. Aikenist Company Information Table 86. Aikenist Business Overview Table 87. Aikenist Brain AI-assisted Diagnosis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Aikenist Brain AI-assisted Diagnosis Software Product Portfolio Table 89. Aikenist Recent Development Table 90. VUNO Company Information Table 91. VUNO Business Overview Table 92. VUNO Brain AI-assisted Diagnosis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. VUNO Brain AI-assisted Diagnosis Software Product Portfolio Table 94. VUNO Recent Development Table 95. North America Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Brain AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Brain AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Brain AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Brain AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Brain AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Brain AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 109. China Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 110. China Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 111. China Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 112. China Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Brain AI-assisted Diagnosis Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Brain AI-assisted Diagnosis Software Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Brain AI-assisted Diagnosis Software Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Brain AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Brain AI-assisted Diagnosis Software Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Brain AI-assisted Diagnosis Software Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Brain AI-assisted Diagnosis Software Image Figure 2. Global Brain AI-assisted Diagnosis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brain AI-assisted Diagnosis Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-Primes Image Figure 6. Global Brain AI-assisted Diagnosis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Brain AI-assisted Diagnosis Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Brain AI-assisted Diagnosis Software Market Size (US$ Million) & (2021-2032) Figure 12. Global Brain AI-assisted Diagnosis Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Brain AI-assisted Diagnosis Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Brain AI-assisted Diagnosis Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Brain AI-assisted Diagnosis Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Brain AI-assisted Diagnosis Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Brain AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2032) Figure 19. Global Brain AI-assisted Diagnosis Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Brain AI-assisted Diagnosis Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Brain AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2032) Figure 22. North America Brain AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 24. North America Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 25. North America Brain AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 26. United States Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Brain AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 31. Europe Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 32. Europe Brain AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 33. Germany Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Brain AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 43. China Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 44. Asia Brain AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 46. Asia Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 47. Asia Brain AI-assisted Diagnosis Software Revenue Share by Region (2021-2032) Figure 48. Japan Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Brain AI-assisted Diagnosis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032) Figure 56. SAMEA Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032) Figure 57. SAMEA Brain AI-assisted Diagnosis Software Revenue Share by Country (2021-2032) Figure 58. Brazil Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Brain AI-assisted Diagnosis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Deepwise
  • NeuMiva
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX
  • BioMind
  • NANO-X
  • Aikenist
  • VUNO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Brain AI-assisted Diagnosis Software Market by Type
  3. 1.2.1 Global Brain AI-assisted Diagnosis Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-Primes
  6. 1.3 Brain AI-assisted Diagnosis Software Market by Application
  7. 1.3.1 Global Brain AI-assisted Diagnosis Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Brain AI-assisted Diagnosis Software Market Dynamics
  1. 2.1 Brain AI-assisted Diagnosis Software Industry Trends
  2. 2.2 Brain AI-assisted Diagnosis Software Industry Drivers
  3. 2.3 Brain AI-assisted Diagnosis Software Industry Opportunities and Challenges
  4. 2.4 Brain AI-assisted Diagnosis Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Brain AI-assisted Diagnosis Software Market Perspective (2021-2032)
  2. 3.2 Global Brain AI-assisted Diagnosis Software Growth Trends by Region
  3. 3.2.1 Global Brain AI-assisted Diagnosis Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Brain AI-assisted Diagnosis Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Brain AI-assisted Diagnosis Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Brain AI-assisted Diagnosis Software Revenue by Players
  2. 4.1.1 Global Brain AI-assisted Diagnosis Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Brain AI-assisted Diagnosis Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Brain AI-assisted Diagnosis Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Brain AI-assisted Diagnosis Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Brain AI-assisted Diagnosis Software Key Players Headquarters & Area Served
  7. 4.4 Global Brain AI-assisted Diagnosis Software Players, Product Type & Application
  8. 4.5 Global Brain AI-assisted Diagnosis Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Brain AI-assisted Diagnosis Software Market CR5 and HHI
  11. 4.6.3 2025 Brain AI-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3
5 Brain AI-assisted Diagnosis Software Market Size by Type
  1. 5.1 Global Brain AI-assisted Diagnosis Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Brain AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 5.3 Global Brain AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2032)
6 Brain AI-assisted Diagnosis Software Market Size by Application
  1. 6.1 Global Brain AI-assisted Diagnosis Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Brain AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  3. 6.3 Global Brain AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Deepwise
  2. 7.1.1 Deepwise Company Information
  3. 7.1.2 Deepwise Business Overview
  4. 7.1.3 Deepwise Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Deepwise Brain AI-assisted Diagnosis Software Product Portfolio
  6. 7.1.5 Deepwise Recent Developments
  7. 7.2 NeuMiva
  8. 7.2.1 NeuMiva Company Information
  9. 7.2.2 NeuMiva Business Overview
  10. 7.2.3 NeuMiva Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NeuMiva Brain AI-assisted Diagnosis Software Product Portfolio
  12. 7.2.5 NeuMiva Recent Developments
  13. 7.3 G K Healthcare
  14. 7.3.1 G K Healthcare Company Information
  15. 7.3.2 G K Healthcare Business Overview
  16. 7.3.3 G K Healthcare Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 G K Healthcare Brain AI-assisted Diagnosis Software Product Portfolio
  18. 7.3.5 G K Healthcare Recent Developments
  19. 7.4 Sense Time
  20. 7.4.1 Sense Time Company Information
  21. 7.4.2 Sense Time Business Overview
  22. 7.4.3 Sense Time Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sense Time Brain AI-assisted Diagnosis Software Product Portfolio
  24. 7.4.5 Sense Time Recent Developments
  25. 7.5 United Imaging
  26. 7.5.1 United Imaging Company Information
  27. 7.5.2 United Imaging Business Overview
  28. 7.5.3 United Imaging Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 United Imaging Brain AI-assisted Diagnosis Software Product Portfolio
  30. 7.5.5 United Imaging Recent Developments
  31. 7.6 Infervision
  32. 7.6.1 Infervision Company Information
  33. 7.6.2 Infervision Business Overview
  34. 7.6.3 Infervision Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Infervision Brain AI-assisted Diagnosis Software Product Portfolio
  36. 7.6.5 Infervision Recent Developments
  37. 7.7 Shukun
  38. 7.7.1 Shukun Company Information
  39. 7.7.2 Shukun Business Overview
  40. 7.7.3 Shukun Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Shukun Brain AI-assisted Diagnosis Software Product Portfolio
  42. 7.7.5 Shukun Recent Developments
  43. 7.8 FOSUN AITROX
  44. 7.8.1 FOSUN AITROX Company Information
  45. 7.8.2 FOSUN AITROX Business Overview
  46. 7.8.3 FOSUN AITROX Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 FOSUN AITROX Brain AI-assisted Diagnosis Software Product Portfolio
  48. 7.8.5 FOSUN AITROX Recent Developments
  49. 7.9 BioMind
  50. 7.9.1 BioMind Company Information
  51. 7.9.2 BioMind Business Overview
  52. 7.9.3 BioMind Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BioMind Brain AI-assisted Diagnosis Software Product Portfolio
  54. 7.9.5 BioMind Recent Developments
  55. 7.10 NANO-X
  56. 7.10.1 NANO-X Company Information
  57. 7.10.2 NANO-X Business Overview
  58. 7.10.3 NANO-X Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 NANO-X Brain AI-assisted Diagnosis Software Product Portfolio
  60. 7.10.5 NANO-X Recent Developments
  61. 7.11 Aikenist
  62. 7.11.1 Aikenist Company Information
  63. 7.11.2 Aikenist Business Overview
  64. 7.11.3 Aikenist Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Aikenist Brain AI-assisted Diagnosis Software Product Portfolio
  66. 7.11.5 Aikenist Recent Developments
  67. 7.12 VUNO
  68. 7.12.1 VUNO Company Information
  69. 7.12.2 VUNO Business Overview
  70. 7.12.3 VUNO Brain AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 VUNO Brain AI-assisted Diagnosis Software Product Portfolio
  72. 7.12.5 VUNO Recent Developments
8 North America
  1. 8.1 North America Brain AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 8.2 North America Brain AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 8.3 North America Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Brain AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 8.5 North America Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Brain AI-assisted Diagnosis Software Revenue by Country
  11. 8.6.1 North America Brain AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Brain AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Brain AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Brain AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 9.2 Europe Brain AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 9.3 Europe Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Brain AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 9.5 Europe Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Brain AI-assisted Diagnosis Software Revenue by Country
  11. 9.6.1 Europe Brain AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Brain AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Brain AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Brain AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 10.2 China Brain AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 10.2.1 China Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 10.2.2 China Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 10.3 China Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 10.4 China Brain AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 10.4.1 China Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 10.4.2 China Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 10.5 China Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Brain AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 11.2 Asia Brain AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 11.3 Asia Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Brain AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 11.5 Asia Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Brain AI-assisted Diagnosis Software Revenue by Country
  11. 11.6.1 Asia Brain AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Brain AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Brain AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Brain AI-assisted Diagnosis Software Revenue (2021-2032)
  2. 12.2 SAMEA Brain AI-assisted Diagnosis Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Brain AI-assisted Diagnosis Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Brain AI-assisted Diagnosis Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Brain AI-assisted Diagnosis Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Brain AI-assisted Diagnosis Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Brain AI-assisted Diagnosis Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Brain AI-assisted Diagnosis Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Brain AI-assisted Diagnosis Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Brain AI-assisted Diagnosis Software Revenue by Country
  11. 12.6.1 SAMEA Brain AI-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Brain AI-assisted Diagnosis Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Brain AI-assisted Diagnosis Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst